Individualized therapy for growth hormone deficiency

References

• Tanner J. Auxology. In: The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence, 4th ed. Kappy MS, Blizzard RM, Migeon CJ (Eds), Charles C Thomas, IL, USA, 137 (1994).
   Google Scholar
• Rogol AD, Lawton BL. Body measurements. In: Pediatric Out-patient Procedures. Lohr JA (Ed.), JB Lippincott Co. PA, USA, 1–9 (1991).
   Google Scholar
• Savage MO, Burren CP, Blair JC et al. Growth hormone insensitivity: pathophysiology, diagnosis, clinical variation and future perspectives. Horm. Res. 55, 32–35 (2001).
   PubMedGoogle Scholar
• Gasser T, Kneip A, Ziegler P, Largo R, Prader A. A method for determining the dynamics and intensity of average growth. Ann. Hum. Biol. 17, 459–474 (1990).
   PubMed Web of Science ®Google Scholar
• Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al. CDC growth charts: United States. Adv. Data 314, 1–27 (2000).
   PubMedGoogle Scholar
• Veldhuis JD, Roemmich JN, Richmond EJ et al. Endocrine control of body composition in infancy, childhood, and puberty. Endocr. Rev. 26, 114–146 (2004).
   Google Scholar
• Perez LA, Argente J. Molecular basis of familial growth hormone deficiency. Horm. Res. 42, 189 (1994).
   PubMedGoogle Scholar
• Strasburger CJ, Wu Z, Pflaum CD et al. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement. J. Clin. Endocrinol. Metab. 81, 2613–2620 (1996).
   Google Scholar
• Rosenfeld RG, Albertsson-Wikland K, Cassorla F et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J. Clin. Endocrinol. Metab. 80, 1532–1540 (1995).
   Google Scholar
• Raiti S, Davis WT, Blizzard RM. A comparison of the effects of insulin hypoglycaemia and arginine infusion on release of human growth hormone. Lancet 2, 1182–1183 (1967).
   PubMed Web of Science ®Google Scholar
• Phillips JA III, Cogan JD. Genetic basis of endocrine disease. 6. Molecular basis of familial human growth hormone deficiency. J. Clin. Endocrinol. Metab. 78, 11–16 (1994).
   PubMed Web of Science ®Google Scholar
• Procter AM, Phillips JA III, Cooper DN. The molecular genetics of growth hormone deficiency. Hum. Genet. 103, 255–272 (1998).
   PubMed Web of Science ®Google Scholar
• Parks JS, Brown MR, Hurley DL, Phelps CJ, Wajnrajch MP. Heritable disorders of pituitary development. J. Clin. Endocrinol. Metab. 84, 4362–4370 (1999).
   PubMed Web of Science ®Google Scholar
• Wu W, Cogan JD, Pfaffle RW et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nature Genet. 8, 147–149 (1998).
   Google Scholar
• Sornson MW, Wu W, Dasen JS et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327–333 (1996).
   PubMed Web of Science ®Google Scholar
• Osorio MG, Kopp P, Marui S, Latronico AC, Mendonca BB, Arnhold IJ. Combined pituitary hormone deficiency caused by a novel mutation of a highly conserved residue (F88S) in the homeodomain of PROP-1. J. Clin. Endocrinol. Metab. 85, 2779–2785 (2000).
   PubMed Web of Science ®Google Scholar
• Rosenbloom AL, Almonte AS, Brown MR, Fisher DA, Baumbach L, Parks JS. Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J. Clin. Endocrinol. Metab. 84, 50–57 (1999).
   PubMedGoogle Scholar
• Maheshwari HG, Silverman BL, Dupuis J, Baumann G. Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: dwarfism of Sindh. J. Clin. Endocrinol. Metab. 83, 4065–4074 (1998).
   PubMed Web of Science ®Google Scholar
• Salvatori R, Hayashida CY, Aguiar-Oliveira MH et al. Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J. Clin. Endocrinol. Metab. 84, 917–923 (1999).
   PubMedGoogle Scholar
• Takahashi Y, Kaji H, Okimura Y et al. Brief report: short stature caused by a mutant growth hormone. N. Engl. J. Med. 334, 432–436 (1996).
   PubMedGoogle Scholar
• Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone: a new inborn error of metabolism? Isr. J. Med. Sci. 2, 152–155 (1966).
   Google Scholar
• Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958–2003. J. Clin. Endocrinol. Metab. 89, 1031–1044 (2004).
   PubMed Web of Science ®Google Scholar
• Gubitosi-Klug RA, Cuttler L. Idiopathic short stature. Endocrinol. Metab. Clin. North Am. 34, 565–580 (2005).
   PubMedGoogle Scholar
• Rogol AD, Blethen SL, Sy JP, Veldhuis JD. Do growth hormone (GH) serial sampling insulin-like growth factor 1 (IGF-1) or auxological measurements have an advantage over GH stimulation testing in prediciting the linear growth response to GH therapy? Clin. Endocrinol. (Oxf.) 58, 229–237 (2003).
   PubMedGoogle Scholar
• Attie KM, Carlsson LM, Rundle AC, Sherman BM. Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Co-operative Growth Study. J. Pediatr. 127, 244–250 (1995).
   PubMedGoogle Scholar
• Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP, Rosenfeld RG. The IGF-I generation test revisited: a marker of GH sensitivity. J. Clin. Endocrinol. Metab. 86, 5176–5183 (2001).
   PubMedGoogle Scholar
• Woods KA, Dastot F, Preece MA et al. Phenotype:genotype relationships in growth hormone insensitivity syndrome. J. Clin. Endocrinol. Metab. 82, 3529–3535 (1997).
   PubMed Web of Science ®Google Scholar
• Kofoed EM, Hwa V, Little B et al. Growth hormone insensitivity associated with a STAT5b mutation. N. Engl. J. Med. 349, 1139–1147 (2003).
   PubMed Web of Science ®Google Scholar
• Woods KA, Camacho-Hubner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N. Engl. J. Med. 335, 1389–1391 (1996).
   PubMedGoogle Scholar
• Yamanaka C, Momoi T, Fuisawa I, Kikuchi K. Acquired growth hormone deficiency due to pituitary stalk transection after head trauma in childhood. Eur. J. Pediatr. 152, 99–101 (1993).
   PubMed Web of Science ®Google Scholar
• Cruikshank DP. Breech presentation. Clin. Obstet. Gynecol. 29, 255–263 (1986).
   PubMedGoogle Scholar
• Oerter KE, Kamp GA, Munson PJ et al. Multiple hormone deficiencies in children with hemochromatosis. J. Clin. Endocrinol. Metab. 76, 357–361 (1993).
   PubMed Web of Science ®Google Scholar
• Darzy KH, Shalet SM. Hypopituitarism after cranial irradiation. J. Endocrinol. Invest. 28(5 Suppl.), 78–87 (2005).
   PubMedGoogle Scholar
• Raben MS. Treatment of a pituitary dwarf with human growth hormone. J. Clin. Endocrinol. Metab. 18, 901–903 (1958).
   PubMed Web of Science ®Google Scholar
• Raben MS. Clinical use of human growth hormone. N. Engl. J. Med. 266, 82–86 (1962).
   PubMedGoogle Scholar
• Blethen SL, MacGillivray MH. A risk-benefit assessment of growth hormone use in children. Drug Saf. 17, 303–316 (1997).
   PubMedGoogle Scholar
• Hintz RL. The prismatic case of Creutzfeld-Jakob disease associated with pituitary growth hormone treatment. J. Clin. Endocrinol. Metab. 80, 2298–2301 (1995).
   PubMedGoogle Scholar
• Werther GA, Wang M, Cowell CT. An auxology-based growth hormone program: update on the Australian experience. J. Pediatr. Endocrinol. Metab. 16(Suppl. 3), 613–618 (2003).
   PubMedGoogle Scholar
• Hintz RL, Attie KM, Baptista J, Roche A. Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. N. Engl. J. Med. 340, 502–507 (1999).
   PubMedGoogle Scholar
• Leschek EW, Rose SR, Yanovski JA et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 89, 3138–3139 (2004).
   PubMedGoogle Scholar
• Wit JM, Rekers-Mombarg LT, Cutler GB et al. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J. Pediatr. 146, 45–53 (2005).
   PubMedGoogle Scholar
• Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L. Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch. Pediatr. Adolesc. Med. 156, 230–240 (2002).
   PubMedGoogle Scholar
• Kelnar CJ, Albertsson-Wikland K, Hintz RL, Ranke MB, Rosenfeld RG. Should we treat children with idiopathic short stature? Horm. Res. 52, 150–157 (1999).
   PubMedGoogle Scholar
• Hopwood NJ, Hintz RL, Gertner JM et al. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J. Pediatr. 123, 215–222 (1993).
   PubMedGoogle Scholar
• Growth Hormone Research Society. Critical evaluation of the safety of recombinant human growth hormone administration. J. Clin. Endocrinol. Metab. 86, 1868–1870 (2001).
   PubMed Web of Science ®Google Scholar
• Ranke MB, Schweizer R, Wollmann HA, Schwarze P. Dosing of growth hormone in growth hormone deficiency. Horm. Res. 51(Suppl. 3), 70–74 (1999).
   PubMedGoogle Scholar
• Fujieda K, Hanew K, Hirano T et al. Growth response to growth hormone therapy in patients with different degrees of growth hormone deficiency. Endocr. J. 43, S19–S25 (1996).
   Google Scholar
• Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J. High-dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc, Co-operative Study Group. J. Clin. Endocrinol. Metab. 85, 3653–3660 (2000).
   PubMed Web of Science ®Google Scholar
• Wilson TA, Rose SR, Cohen P et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J. Pediatr. 143, 415–421 (2003).
   PubMed Web of Science ®Google Scholar
• Cohen P, Rogol AD, Howard CP, Kappelgaard A, Rosenfeld RG. IGF-based dosing of growth hormone accelerates the growth velocity of children with growth hormone deficiency (GHD) and idiopathic short stature (ISS). 7th Joint ESPE/LWPES Meeting. Lyon, France, September 2005.
   Google Scholar
• Roemmich JN, Huerta MG, Sundaresan SM, Rogol AD. Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy. Metabolism 50, 537–547 (2001).
   PubMedGoogle Scholar
• Jorgensen JO, Thuesen L, Muller J, Ovesen P, Skakkebaek NE, Christiansen JS. Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur. J. Endocrinol. 130, 224–228 (1994).
   PubMed Web of Science ®Google Scholar
• Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocr. Rev. 19, 55–79 (1998).
   PubMed Web of Science ®Google Scholar
• Richman C, Baylink DJ, Lang K, Dony C, Mohan S. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140, 4699–4705 (1999).
   PubMed Web of Science ®Google Scholar
• Hintz R. The prismatic case of Creutzfeld-Jakob disease associated with pituitary growth hormone treatment. J. Clin. Endocrinol. Metab. 80, 2298–2301 (1995).
   PubMedGoogle Scholar
• Malozowski S, Tanner LA, Wysowski DK, Fleming GA, Stadel BV. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J. Pediatr. 126, 996–999 (1995).
   PubMed Web of Science ®Google Scholar
• Malozowski S, Green L. Premature thelarche in girls following growth hormone therapy. J. Pediatr. 138, 449 (2001).
   PubMedGoogle Scholar
• Seminara S, Merello G, Masi S et al. Effect of long-term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency. Clin. Endocrinol. (Oxf.) 49, 125–130 (1998).
   PubMedGoogle Scholar
• Nishi Y, Tanaka T, Takano K et al. Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan. J. Clin. Endocrinol. Metab. 84, 1961–1965 (1999).
   PubMedGoogle Scholar
• Cohen P, Clemmons DR, Rosenfeld RG. Does the GH–IGF axis play a role in cancer pathogenesis? Growth Horm. IGF Res. 10, 297–305 (2000).
   PubMedGoogle Scholar
• Orme SM, McNally RJ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J. Clin. Endocrinol. Metab. 83, 2730–2734 (1998).
   PubMed Web of Science ®Google Scholar
• Jenkins PJ, Fairclough PD, Richards T et al. Acromegaly, colonic polyps, and carcinoma. Clin. Endocrinol. (Oxf.) 47, 17–22 (1997).
   PubMed Web of Science ®Google Scholar
• Swerdlow J, Higgins CD, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study. Lancet 360, 273–277 (2002).
   Google Scholar
• Sperling MA, Saenger PH, Ray H, Wilson TA, Rose SR. Growth hormone treatment and neoplasia-coincidence or consequence? J. Clin. Endocrinol. Metab. 87, 5351–5352 (2002).
   PubMed Web of Science ®Google Scholar
• Sklar CA, Mertens AC, Mitby P et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J. Clin. Endocrinol. Metab. 87, 3136–3141 (2002).
   PubMed Web of Science ®Google Scholar
• Eiholzer U, NordmannY, L’Allemand D. Fatal outcome of sleep apnea in PWS during the initial phase of growth hormone treatment. A case report. Horm. Res. 58(Suppl. 3), 24–26 (2002).
   PubMedGoogle Scholar
• Grugni G, Livieri C, Corrias A, Sartorio A, Crino A. Death during GH therapy in children with Prader-Willi syndrome: description of two new cases. J. Endocrinol. Invest. 28, 554–557 (2005).
   PubMedGoogle Scholar
• Kemp SF, Kuntze J, Attie KM et al. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. J. Clin. Endocrinol. Metab. 90, 5247–5253 (2005).
   PubMed Web of Science ®Google Scholar